Actualizaciones regulatorias
Novedades regulatorias de FDA, EMA, TGA y organismos globales
#Ranitidine ×
Actualizaciones regulatorias
17 sept 2026•1 min de lectura
FDA Approves ANDA077824 for Ranitidine Tablets by Amneal Pharmaceuticals
The FDA has granted approval for ANDA077824, authorizing Amneal Pharmaceuticals’ oral ranitidine tablets in 150 mg and 300 mg strengths, now listed as discontinued.
Actualizaciones regulatorias
30 ago 2026•1 min de lectura
FDA Approves Ranitidine Oral Syrup (ANDA077405)
The FDA has granted approval for ANDA077405, an oral Ranitidine hydrochloride syrup (15 mg/ml) manufactured by Pharmaceutical Associates, Inc., with labeling updates through 2010.
2